Accessibility Menu
 
Stella Diagnostics logo

Stella Diagnostics

(OTC) SLDX

Current Price$0.02
Market Cap$4.82M
Since IPO (2008)-100%
5 Year-97%
1 Year-67%
1 Month+0%

Stella Diagnostics Financials at a Glance

Market Cap

$4.82M

Revenue (TTM)

$717.97K

Net Income (TTM)

$1.85M

EPS (TTM)

$-0.00

P/E Ratio

-4.10

Dividend

$0.00

Beta (Volatility)

0.57 (Low)

Price

$0.02

Volume

3

Open

$0.02

Previous Close

$0.02

Daily Range

$0.02 - $0.02

52-Week Range

$0.01 - $0.05

SLDX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Stella Diagnostics

Industry

Healthcare Providers and Services

Employees

3

CEO

David Seaburg

Headquarters

Salt Lake City, UT 84104, US

SLDX Financials

Key Financial Metrics (TTM)

Gross Margin

-45%

Operating Margin

-2%

Net Income Margin

-2%

Return on Equity

0%

Return on Capital

6%

Return on Assets

-5%

Earnings Yield

-24.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.82M

Shares Outstanding

301.50M

Volume

3

Short Interest

0.00%

Avg. Volume

7.226

Financials (TTM)

Gross Profit

$660.29K

Operating Income

$3.45M

EBITDA

$3.45M

Operating Cash Flow

$1.30M

Capital Expenditure

$0.00

Free Cash Flow

$1.30M

Cash & ST Invst.

$58.01K

Total Debt

$12.48M

Stella Diagnostics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$516.71K

N/A

Gross Profit

$200.30K

N/A

Gross Margin

-38.77%

N/A

Market Cap

$4.82M

N/A

Market Cap/Employee

$2.41M

N/A

Employees

2

N/A

Net Income

$688.22K

-108.8%

EBITDA

$645.14K

-67.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$2.82M

+57.1%

Accounts Receivable

$10.22K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$20.61K

-97.7%

Short Term Debt

$2.90M

-49.1%

Return on Assets

-5.19%

N/A

Return on Invested Capital

6.29%

N/A

Free Cash Flow

$316.22K

+47.3%

Operating Cash Flow

$316.23K

+47.3%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CNGGFCann Group Limited
$0.01+0.00%
RNVARennova Health, Inc.
$0.00+0.00%
TDSGFTelo Genomics Corp.
$0.04+0.00%
TBRIFTherma Bright Inc.
$0.05+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$188.63+0.03%
INTCIntel
$62.38+0.01%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.61+0.02%
NOKNokia
$9.46-0.01%

Questions About SLDX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.